RCA
GILD icon

Ranch Capital Advisors’s Gilead Sciences GILD Stock Holding History

Ranch Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Buy
29,324
+2,950
+11% +$389K 1.17% 32
2026
Q1 		$3.68M Buy
26,374
+1,443
+6% +$202K 1.33% 24
2025
Q4 		$3.06M Buy
24,931
+1,215
+5% +$148K 1.13% 30
2025
Q3 		$2.63M Buy
23,716
+1,351
+6% +$154K 1.02% 31
2025
Q2 		$2.48M Buy
22,365
+1,323
+6% +$141K 1.08% 29
2025
Q1 		$2.36M Buy
21,042
+1,487
+8% +$153K 1.12% 26
2024
Q4 		$1.81M Buy
19,555
+7,153
+58% +$644K 0.85% 37
2024
Q3 		$1.04M Buy
12,402
+897
+8% +$68.4K 0.49% 63
2024
Q2 		$789K Buy
11,505
+74
+0.6% +$4.94K 0.41% 68
2024
Q1 		$837K Buy
11,431
+215
+2% +$16.5K 0.45% 64
2023
Q4 		$909K Sell
11,216
-4,489
-29% -$349K 0.57% 59
2023
Q3 		$1.18M Buy
15,705
+341
+2% +$26.2K 0.82% 36
2023
Q2 		$1.18M Sell
15,364
-76
-0.5% -$6.06K 0.83% 35
2023
Q1 		$1.28M Buy
15,440
+495
+3% +$41K 0.94% 30
2022
Q4 		$1.28M Sell
14,945
-4,098
-22% -$325K 1% 28
2022
Q3 		$1.18M Buy
19,043
+330
+2% +$20.8K 0.96% 31
2022
Q2 		$1.16M Buy
18,713
+2,136
+13% +$132K 0.89% 34
2022
Q1 		$986K Buy
16,577
+6,193
+60% +$396K 0.65% 47
2021
Q4 		$754K Buy
10,384
+150
+1% +$10.3K 0.49% 65
2021
Q3 		$715K Buy
10,234
+9,931
+3,278% +$698K 0.45% 64
2021
Q2 		$20K Sell
303
-67
-18% -$4.47K 0.01% 488
2021
Q1 		$23K Sell
370
-252
-41% -$16.2K 0.02% 439
2020
Q4 		$36K Buy
622
+4
+0.6% +$241 0.03% 341
2020
Q3 		$39K Buy
618
+3
+0.5% +$208 0.03% 329
2020
Q2 		$42K Sell
615
-1,684
-73% -$129K 0.03% 330
2020
Q1 		$171K Buy
2,299
+1,652
+255% +$114K 0.17% 131
2019
Q4 		$42K Buy
+647
New +$42.1K 0.03% 366

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ranch Capital Advisors's GILD Position: Q2 2026 in Review

Ranch Capital Advisors increased its Gilead Sciences (GILD) stake by 11% in Q2 2026, buying an estimated $389K and bringing the position to 29,324 shares worth $3.7M. The position accounts for 1.17% of the portfolio, ranked #32.

Ranch Capital Advisors first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ranch Capital Advisors held 29,324 shares of Gilead Sciences worth $3.7M as of Q2 2026.
  • Ranch Capital Advisors bought 2,950 Gilead Sciences shares in Q2 2026, an estimated $389K.
  • Gilead Sciences made up 1.17% of Ranch Capital Advisors's portfolio in Q2 2026, its #32 holding.
  • Ranch Capital Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ranch Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.